Mouzaki M - Search Results

1

Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.

Barrow F, Khan S, Fredrickson G, Wang H, Dietsche K, Parthiban P, Robert S, Kaiser T, Winer S, Herman A, Adeyi O, Mouzaki M, Khoruts A, Hogquist KA, Staley C, Winer DA, Revelo XS. Barrow F, et al. Among authors: mouzaki m. Hepatology. 2021 Aug;74(2):704-722. doi: 10.1002/hep.31755. Hepatology. 2021. PMID: 33609303 Free PMC article.

2

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP. Mouzaki M, et al. Hepatology. 2013 Jul;58(1):120-7. doi: 10.1002/hep.26319. Epub 2013 May 14. Hepatology. 2013. PMID: 23401313

3

Randomized placebo-controlled trial of losartan for pediatric NAFLD.

Vos MB, Van Natta ML, Blondet NM, Dasarathy S, Fishbein M, Hertel P, Jain AK, Karpen SJ, Lavine JE, Mohammad S, Miriel LA, Molleston JP, Mouzaki M, Sanyal A, Sharkey EP, Schwimmer JB, Tonascia J, Wilson LA, Xanthakos SA; NASH Clinical Research Network. Vos MB, et al. Among authors: mouzaki m. Hepatology. 2022 Aug;76(2):429-444. doi: 10.1002/hep.32403. Epub 2022 Feb 28. Hepatology. 2022. PMID: 35133671 Free PMC article. Clinical Trial.

4

The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease.

Mouzaki M, Allard JP. Mouzaki M, et al. J Clin Gastroenterol. 2012 Jul;46(6):457-67. doi: 10.1097/MCG.0b013e31824cf51e. J Clin Gastroenterol. 2012. PMID: 22469640 Review.

5

Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease.

Mouzaki M, Bandsma R. Mouzaki M, et al. Curr Drug Targets. 2015;16(12):1324-31. doi: 10.2174/1389450116666150416120351. Curr Drug Targets. 2015. PMID: 25882223 Review.

6

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.

Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Fung S, Fischer SE, McGilvray IG, Allard JP. Mouzaki M, et al. PLoS One. 2016 May 20;11(5):e0151829. doi: 10.1371/journal.pone.0151829. eCollection 2016. PLoS One. 2016. PMID: 27203081 Free PMC article.

7

More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD.

Lam C, Bandsma R, Ling S, Mouzaki M. Lam C, et al. Among authors: mouzaki m. Can J Gastroenterol Hepatol. 2016;2016:8205494. doi: 10.1155/2016/8205494. Epub 2016 Dec 12. Can J Gastroenterol Hepatol. 2016. PMID: 28058253 Free PMC article.

8

Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.

Mouzaki M, Bramlage K, Arce-Clachar AC, Xanthakos SA. Mouzaki M, et al. J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):631-634. doi: 10.1097/MPG.0000000000002104. J Pediatr Gastroenterol Nutr. 2018. PMID: 30363043 Free PMC article.

9

Identifying Predictors of Response to Vitamin E for the Treatment of Pediatric Nonalcoholic Steatohepatitis.

Yodoshi T, Orkin S, Arce-Clachar AC, Bramlage K, Su W, Fei L, Xanthakos SA, Mouzaki M. Yodoshi T, et al. Among authors: mouzaki m. JPEN J Parenter Enteral Nutr. 2020 Sep;44(7):1301-1307. doi: 10.1002/jpen.1766. Epub 2020 Jan 27. JPEN J Parenter Enteral Nutr. 2020. PMID: 31985850 Free PMC article.

10

Evolving Role for Pharmacotherapy in NAFLD/NASH.

Attia SL, Softic S, Mouzaki M. Attia SL, et al. Among authors: mouzaki m. Clin Transl Sci. 2021 Jan;14(1):11-19. doi: 10.1111/cts.12839. Epub 2020 Aug 25. Clin Transl Sci. 2021. PMID: 32583961 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page